Fort Point Capital Partners LLC Ionis Pharmaceuticals Inc Transaction History

Fort Point Capital Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$52.92 - $81.17 $360,067 - $552,280	-6,804 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $291,755 - $365,374	6,804 New	6,804 $351,000
Q2 2018 Aug 13, 2018	SELL	$40.53 - $50.7 $277,589 - $347,244	-6,849 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $301,903 - $377,037	6,849 New	6,849 $302,000
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $392,541 - $502,499	-7,804 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $355,550 - $464,884	7,804	7,804 $396,000

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.8B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Fort Point Capital Partners LLC with notifications on news.